Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,496.22
(
0.70%
)
US TECH 100
28,788.40
(
0.70%
)
Dow Jones
49,973.11
(
0.56%
)
Brent Oil
102.84
(
-0.82%
)
Bitcoin
79,284.82
(
0.00%
)
News Focus
News Focus
Post# of 257559
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 213681

Saturday, 09/16/2017 5:35:34 PM

Saturday, September 16, 2017 5:35:34 PM

Post# of 257559
Re: BMY withdrawal of Opdivo MAA in HCC

That's surprising—I thought the data looked pretty good. If I recall correctly, they have a US PDUFA date later this month for this indication.

Yes, the PDUFA date is 9/24/17 (https://investors.bms.com/iframes/press-releases/press-release-details/2017/US-Food-and-Drug-Administration-Accepts-for-Priority-Review-Bristol-Myers-Squibbs-Application-for-Opdivo-nivolumab-in-Previously-Treated-Hepatocellular-Carcinoma/default.aspx ).

The problem in Europe might be CMC-related, although it would have to something recent insofar as the CHMP endorsed Opdivo as recently as Apr 2017 (#msg-130693584).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today